Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 1, 2012, Pages

  Kim, Hye J ^a   Lee, Jong S ^a   Kim, Jung D ^a   Cha, Hee J ^a   Kim, Ahra ^a   Lee, Sun K ^a   Lee, Sang C ^a   Kwon, Byoung S ^b   Mittler, Robert S ^a,c   Cho, Hong R ^a   Kwon, Byungsuk ^a  

^a University of Ulsan   (South Korea)

^b National Cancer Center   (South Korea)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute inflammation; Costimulatory ligand

Indexed keywords

CD137 ANTIGEN; CD137 LIGAND; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE;

ACUTE DISEASE; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INTRACELLULAR SIGNALING; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; KIDNEY TUBULE EPITHELIUM; MOUSE; NATURAL KILLER CELL; NEPHRITIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; WILD TYPE;

4-1BB LIGAND; ADOPTIVE TRANSFER; ANIMALS; CHEMOKINE CXCL1; CHEMOKINE CXCL2; CHEMOTAXIS; EPITHELIAL CELLS; INFLAMMATION; KIDNEY TUBULES; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; NEUTROPHILS; RECEPTORS, FC; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84862941034     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1112256109     Document Type: Article

References (59)

1. Nathan C (2002) Points of control in inflammation. Nature 420:846-852.
2. Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454: 428-435.
3. Barton GM (2008) A calculated response: Control of inflammation by the innate immune system. J Clin Invest 118:413-420.
4. Leemans JC, et al. (2005) Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115:2894-2903. (Pubitemid 41434417)
5. Wu H, et al. (2007) TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117:2847-2859. (Pubitemid 47529615)
6. Bonventre JV, Weinberg JM (2003) Recent advances in the pathophysiology of ischemic acute renal injury. Am Soc Nephrol 14:2199-2210. (Pubitemid 36909930)
7. Swamy M, Jamora C, Havran W, Hayday A (2010) Epithelial decision makers: In search of the 'epimmunome'. Nat Immunol 11:656-665.
8. Daha MR, van Kooten C (2000) Is the proximal tubular cell a proinflammatory cell? Nephrol Dial Transplant 15(Suppl 6):41-43.
9. Thurman JM, et al. (2007) C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ischemia/reperfusion. J Immunol 178:1818-1828.
10. Molls RR, et al. (2006) Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am J Physiol Renal Physiol 290:F1187-F1193. (Pubitemid 43724919)
11. Cugini D, et al. (2005) Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion. Kidney Int 67:1753-1761. (Pubitemid 40577710)
12. Miura M, Fu X, Zhang QW, Remick DG, Fairchild RL (2001) Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am J Pathol 159:2137-2145. (Pubitemid 33104268)
13. Daemen MA, de Vries B, van't Veer C, Wolfs TG, Buurman WA (2001) Apoptosis and chemokine induction after renal ischemia-reperfusion. Transplantation 71:1007-1011. (Pubitemid 32417369)
14. Furuichi K, Kaneko S, Wada T (2009) Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease. Clin Exp Nephrol 13:9-14.
15. van Kooten C, et al. (1997) Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int 51:711-721.
16. Kwon B (2009) CD137-CD137 ligand interactions in inflammation. Immune Netw 9:84-89.
17. Seo SK, et al. (2003) Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis. J Immunol 171:576-583. (Pubitemid 36871364)
18. Seo SK, et al. (2004) 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat Med 10:1088-1094. (Pubitemid 39424870)
19. Olofsson PS, et al. (2008) CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation 117: 1292-1301. (Pubitemid 351365671)
20. Kim W, et al. (2009) Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease. Biol Blood Marrow Transplant 15:306-314.
21. Haga T, et al. (2009) Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway. J Mol Cell Cardiol 46:719-727.
22. Jeon HJ, et al. (2010) CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice. Circulation 121:1124-1133.
23. Vinay DS, et al. (2004) CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses. J Immunol 173:4218-4229. (Pubitemid 39280788)
24. Kim DH, et al. (2008) 4-1BB engagement costimulates NKT cell ligand-induced airway hyperresponsiveness and inflammation. J Immunol 180:2062-2068.
25. Heinisch IVWM, Daigle I, Knöpfli B, Simon HU (2000) CD137 activation abrogates granulocyte-macrophage colony-stimulating factor-mediated anti-apoptosis in neutrophils. Eur J Immunol 30:3441-3446. (Pubitemid 32005215)
26. Heinisch IVWM, Bizer C, Volgger W, Simon HU (2001) Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders. J Allergy Clin Immunol 108:21-28. (Pubitemid 32662228)
27. Nishimoto H, et al. (2005) Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. Blood 106:4241-4248. (Pubitemid 41775932)
28. Shao Z, Schwarz H (2011) CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction. J Leukoc Biol 89:21-29.
29. Langstein J, et al. (1998) CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J Immunol 160:2488-2494. (Pubitemid 28119935)
30. Lippert U, et al. (2008) CD137 ligand reverse signaling has multiple functions in human dendritic cells during an adaptive immune response. Eur J Immunol 38:1024-1032.
31. Lee SW, et al. (2008) Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells. Nat Immunol 9:917-926.
32. Ueda Y, Kondo M, Kelsoe G (2005) Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med 201:1771-1780. (Pubitemid 41002896)
33. Nagai Y, et al. (2006) Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24:801-812. (Pubitemid 43867369)
34. Li L, et al. (2010) IL-17 produced by neutrophils regulates IFN-γ-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 120:331-342.
35. Zhang ZX, et al. (2008) NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J Immunol 181:7489-7498.
36. Boros P, Bromberg JS (2006) New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant 6:652-658. (Pubitemid 43345001)
37. Jang HR, Rabb H (2009) The innate immune response in ischemic acute kidney injury. Clin Immunol 130:41-50.
38. Shigeoka AA, et al. (2007) TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol 178:6252-6258. (Pubitemid 46717408)
39. Pulskens WP, et al. (2008) Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS ONE 3:e3596.
40. Lünemann A, Lünemann JD, Münz C (2009) Regulatory NK-cell functions in inflammation and autoimmunity. Mol Med 15:352-358.
41. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S (2008) Functions of natural killer cells. Nat Immunol 9:503-510. (Pubitemid 351560519)
42. Zhang ZX, et al. (2010) Osteopontin expressed in tubular epithelial cells regulates NK cell-mediated kidney ischemia reperfusion injury. J Immunol 185:967-973.
43. Melero I, Johnston JV, Shufford WW, Mittler RS, Chen L (1998) NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell Immunol 190:167-172. (Pubitemid 29011104)
44. + cytolytic T cells and responsiveness to IL-2 but not cytolytic activity. J Immunol 169:4230-4236.
45. Kang YJ, et al. (2007) Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages. Nat Immunol 8:601-609. (Pubitemid 46785124)
46. Croft M (2009) The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 9:271-285.
47. Sun Y, et al. (2002) Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J Immunol 168: 1457-1465. (Pubitemid 34094519)
48. Polte T, et al. (2006) CD137-mediated immunotherapy for allergic asthma. J Clin Invest 116:1025-1036.
49. Sun Y, et al. (2002) Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat Med 8:1405-1413. (Pubitemid 36019426)
50. Foell J, et al. (2003) CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice. J Clin Invest 111:1505-1518. (Pubitemid 38063283)
51. Kim J, et al. (2005) Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells. Blood 105: 2206-2213. (Pubitemid 40731814)
52. + T cells. Blood 110:776-782.
53. Zhang B, et al. (2007) Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent. J Clin Invest 117:3029-3041. (Pubitemid 47529632)
54. Kwon BS, et al. (2002) Immune responses in 4-1BB (CD137)-deficient mice. J Immunol 168:5483-5490. (Pubitemid 34556126)
55. Choi BK, et al. (2009) 4-1BB functions as a survival factor in dendritic cells. J Immunol 182:4107-4115.
56. DeBenedette MA, et al. (1999) Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J Immunol 163:4833-4841. (Pubitemid 29501247)
57. Hayden MS, et al. (1996) Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigen. Tissue Antigens 48:242-254. (Pubitemid 26377563)
58. Barsoum J (1990) Introduction of stable high-copy-number DNA into Chinese hamster ovary cells by electroporation. DNA Cell Biol 9:293-300.
59. Day YJ, et al. (2003) Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J Clin Invest 112:883-891.